NeuExcell is a series a startup based in United States. 1 investor tracked on Brouky Intelligence. Data sourced from Brouky Intelligence.
About
NeuExcell is a gene therapy company focused on developing neuro-regenerative therapies for neurodegenerative diseases, including Huntington's Disease, Parkinson's Disease, and stroke.
Stage
series-a
Investors
1
See full investor history, risk signals & comparable companies
Brouky tracks 15,000+ startups with funding rounds, risk analysis, and AI-powered investor matching.
Subscribe to Brouky